Publications by authors named "Subrahmanya D Vallabhapurapu"

Claim this Profile
T
Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer.
Ahmet Kaynak, Subrahmanya D Vallabhapurapu, Eric P Smith, Harold W Davis, Clayton S Lewis

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors.
Ahmet Kaynak, Subrahmanya D Vallabhapurapu, Harold W Davis, Eric P Smith, Petr Muller

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents.
Ahmet Kaynak, Harold W Davis, Subrahmanya D Vallabhapurapu, Koon Y Pak, Brian D Gray

Pharmaceuticals (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
Harold W Davis, Ahmet Kaynak, Subrahmanya D Vallabhapurapu, Xiaoyang Qi

World J Gastrointest Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity.
Yin Xiao, Musga Qureischi, Lena Dietz, Martin Vaeth, Subrahmanya D Vallabhapurapu

J Exp Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.
Kombo F N'Guessan, Harold W Davis, Zhengtao Chu, Subrahmanya D Vallabhapurapu, Clayton S Lewis

Mol Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Harold W Davis, Subrahmanya D Vallabhapurapu, Zhengtao Chu, Michael A Wyder, Kenneth D Greis

Cells· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
Harold W Davis, Subrahmanya D Vallabhapurapu, Zhengtao Chu, Swarajya L Vallabhapurapu, Robert S Franco

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
Subrahmanya D Vallabhapurapu, Sunil K Noothi, Derek A Pullum, Charles H Lawrie, Rachel Pallapati, Sivakumar Vallabhapurapu

Nat Commun· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.
Subrahmanya D Vallabhapurapu, Víctor M Blanco, Mahaboob K Sulaiman, Swarajya Lakshmi Vallabhapurapu, Zhengtao Chu

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
Mahaboob K Sulaiman, Zhengtao Chu, Victor M Blanco, Subrahmanya D Vallabhapurapu, Robert S Franco

Mol Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.
Víctor M Blanco, Zhengtao Chu, Subrahmanya D Vallabhapurapu, Mahaboob K Sulaiman, Ady Kendler

Oncotarget· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma.
Veena Potluri, Sunil K Noothi, Subrahmanya D Vallabhapurapu, Sang-Oh Yoon, James J Driscoll, Sivakumar Vallabhapurapu

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis